| Name | Cvs Pharmacy #05461 |
|---|---|
| Organization Name | New Jersey Cvs Pharmacy Llc |
| Location | 120 Woodward Rd, Manalapan, New Jersey 07726 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (732) 446-0138 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The prevalence of obesity in the U.S. largely leveled off over the last decade, even as some individual groups, such as boys from ages 6 to 19, saw increases, according to government data. Obesity rates in adults rose slightly to 35.7 percent from 30.5 percent between 1999 and 2010, compared with rates that nearly doubled in the two previous decades, the Centers for Disease Control and Prevention reported today. The rate among boys climbed 29 percent, surpassing girls for the first time, according to the Atlanta-based health agency.
"The time of neglecting malaria in pregnancy (MIP) should be over," Bill Brieger, senior malaria specialist at JHPIEGO, writes in a Malaria Matters blog post summarizing a session on malaria and maternal health at the recently concluded Global Health Council annual conference.
Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the initiation of its Phase IIa multicentric clinical trial of GQC101, entitled QUID HF (QUantum Genomics Incremental Dosing in Heart Failure), for the treatment of patients with chronic heart failure. The first three clinical centres of the European trial have been opened in France and Norway.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
Women, who suffer from an extreme form of morning sickness called hyperemesis gravidarum (HG), are shelling out $7,000 for a drug not yet approved for use by expectant mums because they are desperate to control their illness. HG leads to severe nausea, dehydration and fatigue and may require hospitalization. It affects up to 3 per cent of pregnant women - about 9,000 per year in Australia. It may lead to termination of the pregnancy.
› Verified 5 days ago
| NPI Number | 1780879221 |
| Organization Name | NEW JERSEY CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY #05461 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 120 Woodward Road, Manalapan, NJ 07726 |
| Phone Number | 732-446-0138 |
News Archive
The prevalence of obesity in the U.S. largely leveled off over the last decade, even as some individual groups, such as boys from ages 6 to 19, saw increases, according to government data. Obesity rates in adults rose slightly to 35.7 percent from 30.5 percent between 1999 and 2010, compared with rates that nearly doubled in the two previous decades, the Centers for Disease Control and Prevention reported today. The rate among boys climbed 29 percent, surpassing girls for the first time, according to the Atlanta-based health agency.
"The time of neglecting malaria in pregnancy (MIP) should be over," Bill Brieger, senior malaria specialist at JHPIEGO, writes in a Malaria Matters blog post summarizing a session on malaria and maternal health at the recently concluded Global Health Council annual conference.
Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the initiation of its Phase IIa multicentric clinical trial of GQC101, entitled QUID HF (QUantum Genomics Incremental Dosing in Heart Failure), for the treatment of patients with chronic heart failure. The first three clinical centres of the European trial have been opened in France and Norway.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
Women, who suffer from an extreme form of morning sickness called hyperemesis gravidarum (HG), are shelling out $7,000 for a drug not yet approved for use by expectant mums because they are desperate to control their illness. HG leads to severe nausea, dehydration and fatigue and may require hospitalization. It affects up to 3 per cent of pregnant women - about 9,000 per year in Australia. It may lead to termination of the pregnancy.
› Verified 5 days ago
News Archive
The prevalence of obesity in the U.S. largely leveled off over the last decade, even as some individual groups, such as boys from ages 6 to 19, saw increases, according to government data. Obesity rates in adults rose slightly to 35.7 percent from 30.5 percent between 1999 and 2010, compared with rates that nearly doubled in the two previous decades, the Centers for Disease Control and Prevention reported today. The rate among boys climbed 29 percent, surpassing girls for the first time, according to the Atlanta-based health agency.
"The time of neglecting malaria in pregnancy (MIP) should be over," Bill Brieger, senior malaria specialist at JHPIEGO, writes in a Malaria Matters blog post summarizing a session on malaria and maternal health at the recently concluded Global Health Council annual conference.
Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the initiation of its Phase IIa multicentric clinical trial of GQC101, entitled QUID HF (QUantum Genomics Incremental Dosing in Heart Failure), for the treatment of patients with chronic heart failure. The first three clinical centres of the European trial have been opened in France and Norway.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
Women, who suffer from an extreme form of morning sickness called hyperemesis gravidarum (HG), are shelling out $7,000 for a drug not yet approved for use by expectant mums because they are desperate to control their illness. HG leads to severe nausea, dehydration and fatigue and may require hospitalization. It affects up to 3 per cent of pregnant women - about 9,000 per year in Australia. It may lead to termination of the pregnancy.
› Verified 5 days ago
Essential Steps Inc Type: Medicare Supplier Location: 200 Craig Rd, Manalapan, New Jersey 07726 Phone: (732) 423-3222 | |
Cvs Pharmacy #02508 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 253 Gordons Corner Rd, Manalapan, New Jersey 07726 Phone: (732) 536-0400 | |
Cvs Pharmacy #05461 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 120 Woodward Rd, Manalapan, New Jersey 07726 Phone: (732) 446-0138 | |
Cvs Pharmacy #16542 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 55 Us Highway 9, Manalapan, New Jersey 07726 Phone: (732) 294-5197 | |
Wegmans Pharmacy #095 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 55 Us Hwy Route 9 South, Manalapan, New Jersey 07726 Phone: (732) 625-4145 |